Viewing nowZabia 50 mg Tablets (Sitagliptin Hydrochloride Hydrate)
Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Unimed Pharmaceutical Co., Ltd.

MFDS item code 202301972 · Approved 2023.06.27 · Insurance code 649508340
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used to help control blood sugar levels in patients with type 2 diabetes. It can be administered alone or in combination with other medications while following dietary changes and exercise therapy. This allows for effective management of blood sugar and aids in the treatment of diabetes.
This medicine is administered at 100 mg once daily when used as monotherapy or in combination therapy, with a maximum daily dose of 100 mg. It may be taken with or without food. When administered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Because dosage adjustment is required based on renal function, evaluation of renal function is recommended before starting treatment and periodically thereafter. No dosage adjustment is necessary in patients with mild renal impairment (eGFR ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). No dosage adjustment is necessary in patients with moderate renal impairment (eGFR ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). In patients with moderate renal impairment (eGFR ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2), administer 50 mg once daily. In patients with severe renal impairment (eGFR ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (eGFR < 15 mL/min/1.73 m2), administer 25 mg once daily. This medicine may be administered regardless of the timing of dialysis.
This medication may cause severe allergic reactions after administration, so if you experience symptoms such as skin rash or difficulty breathing, you should stop taking the medication immediately and consult a physician. Additionally, this medication can cause serious pancreatic inflammation known as pancreatitis, so if symptoms such as abdominal pain, vomiting, or loss of appetite occur, you should inform healthcare professionals immediately. This medication should not be used in patients with type 1 diabetes or diabetic ketoacidosis, and should not be administered if there is a severe allergic reaction to this medication or the ingredients. Patients with reduced kidney function may have delayed elimination of this medication, so dosage adjustment may be necessary, and it is important to undergo periodic kidney function tests. Hypoglycemic symptoms may occur while on this medication, so when used with insulin or sulfonylurea, dosage adjustments might be needed to reduce the risk of hypoglycemia. Furthermore, if symptoms such as joint pain or skin blistering occur, you should inform your physician immediately and cease taking the medication. It is recommended that pregnant or breastfeeding women do not use this medication and that it is avoided in children under 18 years, as safety and efficacy have not been established. Elderly patients may have reduced kidney function, so it is important to assess kidney function before and after administration and use with caution. In case of overdose, appropriate treatment should be sought immediately at a medical facility, as this medication can be partially removed by hemodialysis, and dialysis treatment may be considered if necessary.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air and moisture from entering, and it is safest to keep it at room temperature between 1 to 30 degrees Celsius. Storing it this way helps maintain the medication's effectiveness and prevents deterioration.
Bright orange, biconvex, round film-coated tablet
30 tablets/box [10T/PTP*3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Unimed Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Korea United Pharm., Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.